Not bad for a company that was born out of a good deed.

FORBES: Marketing Indian Drugs to Americans

Well, Goldman, who never met a regulation she didn't like, is back in government, this time as a senior science advisor at the FDA. Yet another example of the Washington tradition that no bad deed goes unrewarded.

FORBES: Commentary